Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Emil Kakkis
Age : 60
Public asset : 115,066,905 USD
Country of residence : Unknown
Linked companies : Ultragenyx Pharmaceutical Inc.

Biography of Emil Kakkis 
Emil D. Kakkis founded Ultragenyx Pharmaceutical, Inc. and Everylife Foundation for Rare Diseases. Dr. Kakkis occupies the position of President, Chief Executive Officer & Director at Ultragenyx Pharmaceutical, Inc. Dr. Kakkis is also on the board of Emil Kakkis & Jenny Soriano Living Trust and Odylia Therapeutics and President of Everylife Foundation for Rare Diseases. In his past career Dr. Kakkis was Chief Medical Officer & Senior Vice President for BioMarin Pharmaceutical, Inc. and Assistant Professor at Harbor-UCLA Medical Center. Dr. Kakkis received an undergraduate degree from Pomona College and a doctorate from David Geffen School of Medicine.


Current positions of Emil Kakkis 
Holdings of Emil Kakkis 
Emil Kakkis : Personal Network 
Most Read News 
11/20Buffett's Berkshire boosts stakes in Japan's five biggest trading houses
RE
11/17Brazil's Buffett-backed StoneCo nearly doubles profits on more users, bigger prices
RE
11/23Berkshire Hathaway says Warren Buffett donates shares to family charities
RE
11/18Gates Foundation pledges $7 billion for Africa as Ukraine war diverts donor cash
RE
11/17After Elon Musk's ultimatum, Twitter employees start exiting
RE
11/14Buffett-backed Nubank's revenue surges on robust customer growth
RE
11/12Musk to join G20 summit in Indonesia virtually - CNBC Indonesia
RE
11/18Musk's pay trial asks if Tesla's growth justifies $56 billion compensation
RE
11/14Sorrell's S4 Capital defies tech turmoil to maintain momentum
RE
11/16Twitter's ex-CEO Jack Dorsey says will not retake role
RE
More news


© 2022 People and Ownership :   
Emil Kakkis : Connections 


Latest news about Emil Kakkis 
11/17Transcript : Ultragenyx Pharmaceutical Inc. Presents at 13th Annual Jefferies London Healthcare Conference 2022, Nov-17-2022 10:25 AM
CI
11/15Transcript : Ultragenyx Pharmaceutical Inc. Presents at Stifel 2022 Healthcare Conference, Nov-15-2022 01:50 PM
CI
11/02Transcript : Ultragenyx Pharmaceutical Inc., Q3 2022 Earnings Call, Nov 02, 2022
CI
07/28Transcript : Ultragenyx Pharmaceutical Inc., Q2 2022 Earnings Call, Jul 28, 2022
CI
07/18Transcript : Ultragenyx Pharmaceutical Inc. - Special Call
CI
07/18Ultragenyx Pharma Acquires GeneTx After 'Encouraging' Angelman Syndrome Trial Data
MT
06/16Transcript : Ultragenyx Pharmaceutical Inc. Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, Jun-16-2022 10:00 AM
CI
More news